TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bioconnect AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
11,461
|
9,225
|
8,205 |
| Financial expenses |
91
|
90
|
69 |
| Earnings before taxes |
28,377
|
2,208
|
1,325 |
| Total assets |
32,931
|
4,635
|
2,812 |
| Current assets |
32,223
|
4,163
|
2,276 |
| Current liabilities |
13,816
|
1,450
|
1,339 |
| Equity capital |
19,105
|
3,183
|
1,470 |
| - share capital |
100
|
100
|
100 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
58.0%
|
68.7%
|
52.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
247.6%
|
23.9%
|
16.1% |
| Return on assets (ROA) |
86.4%
|
49.6%
|
49.6% |
| Current ratio |
233.2%
|
287.1%
|
170.0% |
| Return on equity (ROE) |
148.5%
|
69.4%
|
90.1% |
| Change turnover |
2,236
|
1,020
|
-1,918 |
| Change turnover % |
24%
|
12%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.